|
|
Volumn 163, Issue 8, 2006, Pages 1316-1318
|
|
Tardive dyskinesia circa 2006
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
DOPAMINE RECEPTOR BLOCKING AGENT;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERPHENAZINE;
AKATHISIA;
DRUG DOSE REDUCTION;
DRUG EXPOSURE;
EDITORIAL;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
METABOLIC SYNDROME X;
MOTOR DYSFUNCTION;
PRIORITY JOURNAL;
PSYCHOSIS;
RISK ASSESSMENT;
SCHIZOPHRENIA;
SIDE EFFECT;
TARDIVE DYSKINESIA;
WEIGHT GAIN;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DYSKINESIA;
EXTRAPYRAMIDAL SYNDROME;
INCIDENCE;
LONGITUDINAL STUDY;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STATISTICS;
TREATMENT OUTCOME;
ANTIPSYCHOTIC AGENTS;
BASAL GANGLIA DISEASES;
DYSKINESIA, DRUG-INDUCED;
HUMANS;
INCIDENCE;
LONGITUDINAL STUDIES;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
|
EID: 33748336475
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/ajp.2006.163.8.1316 Document Type: Editorial |
|
Times cited : (52)
|
|
References (7)
|
